Free Trial

Chugai Pharmaceutical (CHGCY) Short Interest Ratio & Short Volume

Chugai Pharmaceutical logo
$28.88 +4.97 (+20.79%)
As of 04/17/2025 03:59 PM Eastern

Chugai Pharmaceutical Short Interest Data

Chugai Pharmaceutical (CHGCY) has a short interest of 53,600 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a -53.23% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 225,471 shares to cover all short positions.

Current Short Interest
53,600 shares
Previous Short Interest
114,600 shares
Change Vs. Previous Month
-53.23%
Dollar Volume Sold Short
$1.22 million
Short Interest Ratio
0.2 Days to Cover
Last Record Date
March 31, 2025
Outstanding Shares
3,291,028,000 shares
Short Percent of Float
0.00%
Today's Trading Volume
366,799 shares
Average Trading Volume
225,471 shares
Today's Volume Vs. Average
163%
Short Selling Chugai Pharmaceutical?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Chugai Pharmaceutical and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CHGCY Short Interest Over Time

CHGCY Days to Cover Over Time

CHGCY Percentage of Float Shorted Over Time

Chugai Pharmaceutical Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202553,600 shares $1.22 million -53.2%0.0%0.2 $22.71
3/15/2025114,600 shares $2.68 million +165.9%0.0%0.3 $23.40
2/28/202543,100 shares $1.08 million +498.6%0.0%0.2 $25.02
2/15/20257,200 shares $170,496.00 -11.1%0.0%0 $23.68
1/31/20258,100 shares $175,041.00 -93.4%N/A0 $21.61
1/15/2025123,100 shares $2.65 million +234.5%N/A0.3 $21.54
12/31/202436,800 shares $808,496.00 +1,500.0%N/A0.2 $21.97
12/15/20242,300 shares $49,381.00 -88.7%N/A0 $21.47
11/30/202420,400 shares $448,800.00 +39.7%N/A0.1 $22.00
11/15/202414,600 shares $333,902.00 -57.4%N/A0.1 $22.87
10/31/202434,300 shares $817,369.00 -90.8%N/A0.2 $23.83
10/15/2024374,300 shares $9.27 million +3,333.9%N/A0.5 $24.76
9/30/202410,900 shares $262,581.00 -59.0%N/A0.1 $24.09
9/15/202426,600 shares $631,218.00 +6,550.0%N/A0.2 $23.73
8/31/2024400 shares $10,056.00 -96.9%N/A0 $25.14
8/15/202412,900 shares $288,702.00 +545.0%N/A0.1 $22.38
7/31/20242,000 shares $43,600.00 -90.3%N/A0 $21.80
7/15/202420,700 shares $411,723.00 +19.7%N/A0.1 $19.89
6/30/202417,300 shares $307,421.00 +188.3%N/A0.1 $17.77
6/15/20246,000 shares $93,900.00 +66.7%N/A0 $15.65
5/31/20243,600 shares $54,684.00 -96.0%N/A0 $15.19
5/15/202490,300 shares $1.41 million +3,125.0%N/A0.5 $15.64
4/30/20242,800 shares $44,352.00 -94.7%N/A0 $15.84
4/15/202453,000 shares $863,370.00 -52.3%N/A0.1 $16.29
3/31/2024111,100 shares $2.13 million +439.3%N/A0.5 $19.13
3/15/202420,600 shares $414,884.00 -17.6%N/A0.2 $20.14
2/29/202425,000 shares $498,000.00 +635.3%N/A0.1 $19.92
2/15/20243,400 shares $65,076.00 -75.0%N/A0 $19.14
1/15/20243,500 shares $70,840.00 +40.0%N/A0 $20.24
12/31/20232,500 shares $47,125.00 -89.9%N/A0 $18.85
12/15/202324,800 shares $458,800.00 +140.8%N/A0.2 $18.50
11/30/202310,300 shares $180,765.00 -81.1%N/A0.1 $17.55
11/15/202354,400 shares $844,832.00 +246.5%N/A0.4 $15.53
10/31/202315,700 shares $232,988.00 +481.5%N/A0.1 $14.84
10/15/20232,700 shares $41,796.00 -18.2%N/A0 $15.48
9/30/20233,300 shares $50,787.00 -89.6%N/A0 $15.39
9/15/202331,800 shares $481,770.00 -0.9%N/A0.3 $15.15
8/31/202332,100 shares $489,139.80 +22.5%N/A0.2 $15.24
8/15/202326,200 shares $383,044.00 -21.1%N/A0.1 $14.62
7/31/202333,200 shares $495,676.00 +654.6%N/A0 $14.93
BREAKING: Trump Bans NVIDIA Chips to China (Ad)

On April 16th, 2025, President Trump banned Nvidia from selling its most advanced semiconductors to China. That brings the U.S. and China closer to war than at any time since the Korean War ended in 1953.

There's a good chance you own at least one of these through a brokerage account, mutual fund, 401K,
7/15/20234,400 shares $61,204.00 -77.0%N/A0 $13.91
6/30/202319,100 shares $271,984.00 -33.7%N/A0.2 $14.24
6/15/202328,800 shares $425,865.60 -31.6%N/A0.3 $14.79
5/31/202342,100 shares $565,398.79 +109.5%N/A0.3 $13.43
5/15/202320,100 shares $267,631.50 +528.1%N/A0.2 $13.32
4/30/20233,200 shares $41,088.00 -81.8%N/A0 $12.84
4/15/202317,600 shares $218,944.00 +17,500.0%N/A0.1 $12.44
3/31/2023100 shares $1,229.00 -99.3%N/A0 $12.29
3/15/202315,100 shares $184,371.00 -75.7%N/A0.1 $12.21
2/28/202362,000 shares $768,800.00 -39.0%N/A0.3 $12.40
2/15/2023101,700 shares $1.36 million +258.1%N/A0.7 $13.38
1/31/202328,400 shares $366,644.00 -38.4%N/A0.2 $12.91
1/15/202346,100 shares $572,562.00 -22.4%N/A0.1 $12.42
12/30/202259,400 shares $752,598.00 -40.8%N/A0.1 $12.67
12/15/2022100,300 shares $1.28 million +234.3%N/A0.4 $12.76
11/30/202230,000 shares $395,400.00 +689.5%N/A0.2 $13.18
11/15/20223,800 shares $46,892.00 -51.3%N/A0 $12.34
10/31/20227,800 shares $90,012.00 -93.3%N/A0 $11.54
10/15/2022115,900 shares $1.45 million +1,769.4%N/A0.4 $12.52
9/30/20226,200 shares $77,128.00 -43.6%N/A0 $12.44
9/15/202211,000 shares $135,850.00 -86.8%N/A0 $12.35
8/31/202283,100 shares $1.07 million +47.1%N/A0.6 $12.90
8/15/202256,500 shares $815,860.00 +11.2%N/A0.4 $14.44
7/31/202250,800 shares $710,946.00 -17.3%N/A0.3 $14.00
7/15/202261,400 shares $823,957.30 -73.8%N/A0.2 $13.42
6/30/2022234,000 shares $2.99 million +371.8%N/A0.7 $12.77
6/15/202249,600 shares $628,432.00 +1,205.3%N/A0.1 $12.67
5/31/20223,800 shares $51,452.00 -91.2%N/A0 $13.54
5/15/202243,000 shares $594,690.00 -6.7%N/A0.1 $13.83
4/30/202246,100 shares $688,273.00 +108.6%N/A0.1 $14.93
4/15/202222,100 shares $371,722.00 -59.1%N/A0.1 $16.82
3/31/202254,000 shares $899,640.00 +130.8%N/A0.5 $16.66
3/15/202223,400 shares $367,380.00 -67.8%N/A0.1 $15.70
2/28/202272,700 shares $1.21 million -34.5%N/A0.3 $16.64
2/15/2022111,000 shares $1.92 million -23.2%N/A0.6 $17.34
1/31/2022144,500 shares $2.35 million +5.4%N/A0.3 $16.23
1/15/2022137,100 shares $2.27 million +1,328.1%N/A0.5 $16.53
12/31/20219,600 shares $157,056.00 +2.1%N/A0.1 $16.36
12/15/20219,400 shares $154,959.00 -69.5%N/A0 $16.49
11/30/202130,800 shares $499,114.00 +30.0%N/A0.1 $16.21
11/15/202123,700 shares $437,265.00 +1.3%N/A0.2 $18.45
10/29/202123,400 shares $436,644.00 +185.4%N/A0.2 $18.66
10/15/20218,200 shares $142,680.00 -9.9%N/A0.1 $17.40
9/30/20219,100 shares $167,076.00 -33.6%N/A0.1 $18.36
9/15/202113,700 shares $260,300.00 -81.3%N/A0.2 $19.00
8/31/202173,200 shares $1.43 million +90.1%N/A0.7 $19.50
8/13/202138,500 shares $717,255.00 +4.6%N/A0.3 $18.63
7/30/202136,800 shares $676,384.00 -9.1%N/A0.3 $18.38
7/15/202140,500 shares $756,135.00 -16.5%N/A0.4 $18.67
6/30/202148,500 shares $965,635.00 +53.0%N/A0.5 $19.91
BREAKING: Trump Bans NVIDIA Chips to China (Ad)

On April 16th, 2025, President Trump banned Nvidia from selling its most advanced semiconductors to China. That brings the U.S. and China closer to war than at any time since the Korean War ended in 1953.

There's a good chance you own at least one of these through a brokerage account, mutual fund, 401K,
6/15/202131,700 shares $652,386.00 +80.1%N/A0.4 $20.58
5/28/202117,600 shares $333,652.00 -30.7%N/A0.2 $18.96
5/14/202125,400 shares $454,914.00 +13.4%N/A0.2 $17.91
4/30/202122,400 shares $426,272.00 +19.2%N/A0.2 $19.03
4/15/202118,800 shares $372,240.00 -64.1%N/A0.1 $19.80
3/31/202152,300 shares $1.06 million -1.0%N/A0.6 $20.21
3/15/202152,800 shares $1.08 million +123.7%N/A0.3 $20.50
2/26/202123,600 shares $565,692.00 -30.8%N/A0.4 $23.97
2/12/202134,100 shares $845,339.00 -14.3%N/A0.6 $24.79
1/29/202139,800 shares $1.07 million +106.2%N/A0.4 $26.84
1/15/20213,100 shares $86,459.00 +933.3%N/A0.1 $27.89
12/31/202019,400 shares $513,906.00 +525.8%N/A0.3 $26.49
12/15/20203,100 shares $74,989.00 +933.3%N/A0.1 $24.19
11/30/2020300 shares $6,948.00 No ChangeN/A0 $23.16
11/15/2020300 shares $6,574.50 -94.9%N/A0 $21.92
10/30/20205,900 shares $115,817.00 +1,866.7%N/A0.1 $19.63
10/15/2020300 shares $6,513.00 -97.7%N/A0 $21.71
9/30/202013,100 shares $293,440.00 -44.0%N/A0.2 $22.40
9/15/202023,400 shares $527,436.00 +485.0%N/A0.2 $22.54
8/31/20204,000 shares $88,564.00 -70.2%N/A0.1 $22.14
8/14/202013,400 shares $310,746.00 +47.3%N/A0.2 $23.19
7/31/20209,100 shares $205,296.00 -46.2%N/A0.1 $22.56
7/15/202016,900 shares $425,880.00 +275.6%N/A0.2 $25.20
6/30/20204,500 shares $1.47 million +73.1%N/A0.7 $326.77
6/15/20202,600 shares $788,710.00 -31.6%N/A0.3 $303.35
5/29/20203,800 shares $1.11 million +3,700.0%N/A0.5 $292.00
5/15/2020100 shares $24,475.00 -88.9%N/A0 $244.75
4/30/2020900 shares $213,390.00 +800.0%N/A0.1 $237.10

CHGCY Short Interest - Frequently Asked Questions

What is Chugai Pharmaceutical's current short interest?

Short interest is the volume of Chugai Pharmaceutical shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 53,600 shares of CHGCY short. 0.00% of Chugai Pharmaceutical's shares are currently sold short. Learn More on Chugai Pharmaceutical's current short interest.

What is a good short interest percentage for Chugai Pharmaceutical?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Chugai Pharmaceutical's floating shares are currently sold short.

Is Chugai Pharmaceutical's short interest increasing or decreasing?

Chugai Pharmaceutical saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 53,600 shares, a decline of 53.2% from the previous total of 114,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Chugai Pharmaceutical's short interest compare to its competitors?

0.00% of Chugai Pharmaceutical's shares are currently sold short. Here is how the short interest of companies compare to Chugai Pharmaceutical: McKesson Co. (1.49%), Cencora, Inc. (3.79%), Cardinal Health, Inc. (1.96%), Herbalife Ltd. (15.55%), Nu Skin Enterprises, Inc. (4.85%), Cosmos Health Inc. (3.85%), HWH International Inc. (2.11%), Novo Nordisk A/S (0.33%), Roche Holding AG (0.05%), Abbott Laboratories (1.27%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

What does it mean to sell short Chugai Pharmaceutical stock?

Short selling CHGCY is an investing strategy that aims to generate trading profit from Chugai Pharmaceutical as its price is falling. CHGCY shares are trading up $4.97 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Chugai Pharmaceutical?

A short squeeze for Chugai Pharmaceutical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CHGCY, which in turn drives the price of the stock up even further.

How often is Chugai Pharmaceutical's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CHGCY, twice per month. The most recent reporting period available is March, 31 2025.




This page (OTCMKTS:CHGCY) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners